BPG is committed to discovery and dissemination of knowledge
Retrospective Cohort Study
©The Author(s) 2025.
World J Psychiatry. Dec 19, 2025; 15(12): 109437
Published online Dec 19, 2025. doi: 10.5498/wjp.v15.i12.109437
Table 2 Medication use and adherence stratified by depression severity, % (n/total)
Variables
No/mild depression (n = 100)
Moderate/severe depression (n = 60)
Test statistic
P value
β-blocker use68.0 (68/100)53.3 (32/60)χ2 = 3.50.061
ACE inhibitor/ARB use70.0 (70/100)56.7 (34/60)χ2 = 3.70.054
Diuretic use75.0 (75/100)61.7 (37/60)χ2 = 3.00.084
Antidepressant use9.0 (9/100)16.7 (10/60)χ2 = 2.60.107
Anxiolytic use7.0 (7/100)13.3 (8/60)χ2 = 2.90.091
Psychotherapy6.0 (6/100)18.3 (11/60)χ2 = 4.10.043
High adherence (MMAS-4 = 0)40.0 (40/100)25.0 (15/60)χ2 = 4.60.031
Moderate adherence (MMAS-4 = 1-2)38.0 (38/100)40.0 (24/60)χ2 = 0.10.794
Low adherence (MMAS-4 = 3-4)22.0 (22/100)35.0 (21/60)χ2 = 3.90.048


Write to the Help Desk